Prescription Drug Coverage and Medicare Spending among U.S. Elderly

被引:3
|
作者
Shang, Baoping [1 ]
Goldman, Dana [2 ]
机构
[1] Urban Inst, Ctr Hlth Policy, Washington, DC 20037 USA
[2] Univ So Calif, Sch Policy Planning & Dev, Los Angeles, CA 90089 USA
关键词
prescription drugs; health insurance benefits; adverse selection; health care spending; HEALTH-CARE SERVICES; ADVERSE SELECTION; INSURANCE-COVERAGE; PHARMACY BENEFITS; MEDIGAP INSURANCE; COST-CONTAINMENT; IMPACT; COPAYMENT; OUTCOMES; REFORM;
D O I
10.1057/gpp.2010.21
中图分类号
F8 [财政、金融];
学科分类号
0202 ;
摘要
The introduction of Medicare Part D has generated interest in the cost of providing drug coverage to the elderly. Of paramount importance-often unaccounted for in budget estimates-are the salutary effects that increased prescription drug use might have on other Medicare spending. This paper uses longitudinal data from the Medicare Current Beneficiary Survey to estimate how prescription drug benefits affect Medicare spending. We compare spending and service use for Medigap enrollees with and without drug coverage. Owing to concerns about selection, we use variation in supply-side regulations of the individual insurance market-including guaranteed issue and community rating-as instruments for prescription drug coverage. We employ a discrete factor model to control for individual-level heterogeneity that might induce bias in the effects of drug coverage. We find Medigap prescription drug coverage significantly increases drug spending and reduces Medicare Part A spending. Medigap prescription drug coverage reduces Medicare Part B spending, but the estimates are not statistically significant. Furthermore, the substitution effect decreases as income rises, and thus provides support for the low-income assistance program of Medicare Part D. The Geneva Papers (2010) 35, 539-567. doi:10.1057/gpp.2010.21
引用
收藏
页码:539 / 567
页数:29
相关论文
共 50 条
  • [1] Prescription Drug Coverage and Medicare Spending among U.S. Elderly
    Baoping Shang
    Dana Goldman
    [J]. The Geneva Papers on Risk and Insurance - Issues and Practice, 2010, 35 : 539 - 567
  • [2] Prescription drug coverage, utilization, and spending among Medicare beneficiaries
    Davis, M
    Poisal, J
    Chulis, G
    Zarabozo, C
    Cooper, B
    [J]. HEALTH AFFAIRS, 1999, 18 (01) : 231 - 243
  • [3] Prescription drug coverage and spending for Medicare beneficiaries
    Poisal, JA
    Murray, LA
    Chulis, GS
    Cooper, BS
    [J]. HEALTH CARE FINANCING REVIEW, 1999, 20 (03): : 15 - 27
  • [4] Prescription drug coverage and effects on drug expenditures among elderly medicare beneficiaries
    Huh, Soonim
    Rice, Thomas
    Ettner, Susan L.
    [J]. HEALTH SERVICES RESEARCH, 2008, 43 (03) : 810 - 832
  • [5] Prescription drug coverage among Medicare beneficiaries
    Regan, Joseph F.
    Petroski, Cara A.
    [J]. HEALTH CARE FINANCING REVIEW, 2007, 29 (01): : 119 - 125
  • [6] EFFECTS OF MEDICARE PRESCRIPTION DRUG COVERAGE ON NON-DRUG MEDICAL SPENDING
    McWilliams, J. Michael
    Zaslavsky, Alan M.
    Huskamp, Haiden A.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 : S157 - S157
  • [7] Medicare beneficiaries and the impact of gaining prescription drug coverage on inpatient and physician spending
    Briesacher, BA
    Stuart, B
    Ren, XQ
    Doshi, JA
    Wrobel, MV
    [J]. HEALTH SERVICES RESEARCH, 2005, 40 (05) : 1279 - 1296
  • [8] Providing Prescription Drug Coverage to the Elderly: America's Experiment with Medicare Part D
    Duggan, Mark
    Healy, Patrick
    Morton, Fiona Scott
    [J]. JOURNAL OF ECONOMIC PERSPECTIVES, 2008, 22 (04): : 69 - 92
  • [9] Prescription Drug Spending and Medication Adherence Among Medicare Beneficiaries with Heart Failure
    McGee, Blake Tyler
    Phillips, Victoria
    Higgins, Melinda K.
    Butler, Javed
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (06): : 705 - 713
  • [10] Prescription drug spending and hospital use among Medicare beneficiaries with heart failure
    McGee, Blake Tyler
    Higgins, Melinda K.
    Phillips, Victoria
    Butler, Javed
    [J]. RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2020, 16 (10): : 1452 - 1458